Industry News 22 Oct 2026

FDA Approval Of First Potential Hep B Cure Comes Amid Heated Vaccine Debate

Source: Insidehealthpolicy •By daniela •1 min read

Body: FDA’s approval this week of the first functional cure for hepatitis B was celebrated by the Hepatitis B Foundation as a significant step forward in treatment of chronic hepatitis B (CHB). The approval comes as hepatitis B experts worry rates of the disease could rise after Secretary Robert F. Kennedy Jr. and other HHS officials endorsed moving away from the universal birth dose of the hep B vaccine. A modeling study published Tuesday (Oct. 20) found that moving away from the universal hep B vaccine would lead to significantly higher rates of chronic hepatitis B. Kennedy criticized the st

This is a short summary. The full story is published by Insidehealthpolicy.

Read full story at Insidehealthpolicy

Related news

Novo's Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…

Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…

Pr Newswire• 23 Oct 2026 •1 min read
Novo’s Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older…

Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…

Ny Newsly• 23 Oct 2026 •1 min read
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results

Merck and Moderna are preparing to seek FDA approval for a personalized mRNA melanoma vaccine used with Keytruda. No filing date has been set.

Medical Daily• 20 Oct 2026 •1 min read
Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery

FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should…

Inkl• 20 Oct 2026 •1 min read
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.